Arch Venture Management
$1.1B 13F equity value
13 Holdings
Latest filing 2026-06-30
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| PBLS | PARABILIS MEDICINES INC | 6,412,780 | $176M | 16.0% |
| BEAM | BEAM THERAPEUTICS INC | 4,540,132 | $156M | 14.2% |
| RAPP | RAPPORT THERAPEUTICS INC | 3,728,738 | $155M | 14.1% |
| SPTX | SEAPORT THERAPEUTICS INC | 6,294,951 | $137M | 12.4% |
| ERAS | ERASCA INC | 7,091,557 | $130M | 11.8% |
| VIR | VIR BIOTECHNOLOGY INC | 12,694,163 | $129M | 11.8% |
| MAZE | MAZE THERAPEUTICS INC | 4,120,053 | $123M | 11.2% |
| LYEL | LYELL IMMUNOPHARMA INC | 3,247,162 | $46M | 4.1% |
| GENB | GENERATE BIOMEDICINES INC | 1,944,426 | $33M | 3.0% |
| TXG | 10X GENOMICS INC | 217,834 | $8M | 0.8% |
Track Arch Venture Management's 13F portfolio: $1.1B in reported holdings, 13 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}